feed

view company updates

tools

perform investment research

network

join events & discussions

advisory

about us

Redeye Capital

Cantargia: USA-patent för CAN03

Research Note

2018-05-21

08:56

Cantargia har stärkt patentsituationen i USA för bolagets autoimmuna/inflammatoriska program CANxx.

MS

Mathias Spinnars

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.